We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
- Authors
Martelli, M; Vignetti, M; Zinzani, P L; Gherlinzoni, F; Meloni, G; Fiacchini, M; De Sanctis, V; Papa, G; Martelli, M F; Calabresi, F; Tura, S; Mandelli, F
- Abstract
To evaluate, in a prospective multicentric study, the efficacy of a conventional salvage chemotherapy (dexamethasone, cisplatin, and cytarabine [DHAP]) versus high-dose chemotherapy (carmustine, etoposide, cytarabine, and cyclophosphamide [BEAC]) followed by autologous bone marrow transplantation (ABMT) in patients with aggressive non-Hodgkin's lymphoma (NHL) in clinical partial response (PR) after two thirds of a conventional front-line therapy.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Vol 14, Issue 2, p534
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.1996.14.2.534